AVIR
NASDAQ · Pharmaceuticals
Atea Pharmaceuticals Inc
$5.43
-0.11 (-1.99%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+748.1% upside
Low Target
$31.54
Average Target
$46.05
High Target
$64.23
Current Price
$5.43
Current
$5.43
$5.43
Target
$46.05
$46.05
$31.54
$46.05 avg
$64.23
Scenario Analysis
Bear Case
$31.54
480.8%
Low target
Base Case
$46.05
+748.1%
Avg target
Bull Case
$64.23
+1,082.9%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$6.45
-15.8% from high
52-Week Low
$2.46
+121.2% from low
Target vs 52W High
$46.05
+614.0% vs high
Next Earnings Report
May 12, 2026 · After Market Close
1d
tomorrow
EPS Est: $-0.60
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals